Day One Biopharmaceuticals, Inc.DAWNNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank83
3Y CAGR+57.4%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+57.4%/yr
Annual compound
Percentile
P83
Within normal range
vs 3Y Ago
3.9x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $18.45M | -85.7% |
| 2024 | $128.92M | +651.8% |
| 2023 | $17.15M | +262.7% |
| 2022 | $4.73M | +43081.8% |
| 2021 | $-11000.00 | +100.0% |
| 2020 | $-30.06M | -1345.9% |
| 2019 | $-2.08M | - |